Loading…
Loading…
EQUITY / NASDAQ · XNCM
Adial Pharmaceuticals Inc
01 / RESEARCH
8 financial reports are available for research.
Start research ↗4.01 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 4.01 USD · Volume 35,329
22 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Net income | -51,989,000 USD | -1,958,000 USD | — |
| Operating profit | -52,025,000 USD | -1,882,000 USD | — |
| Total assets | 29,089,000 USD | — | — |
| Total equity | -38,377,000 USD | 5,590,000 USD | -786.53% |
| Total liabilities | 28,933,000 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -51,989,000 USD | -54,012,000 USD | -2,023,000 USD | — | -7,977,171 USD | -1,793,651 USD | -5,981,008 USD | -1,958,000 USD |
| Operating profitIncome statement | -52,025,000 USD | -54,027,000 USD | — | — | -7,799,462 USD | -1,764,078 USD | -5,914,083 USD | -1,882,000 USD |
| Total assetsBalance sheet | 29,089,000 USD | — | — | 6,674,000 USD | 6,673,367 USD | 5,659,847 USD | — | — |
| Total equityBalance sheet | -38,377,000 USD | — | 3,717,000 USD | 5,277,000 USD | 5,276,458 USD | 4,505,091 USD | — | 5,590,000 USD |
| Total liabilitiesBalance sheet | 28,933,000 USD | — | — | 1,397,000 USD | 1,396,909 USD | 1,154,756 USD | — | — |
| Financing cash flowCash flow statement | — | 25,524,000 USD | — | — | 8,473,295 USD | — | 5,873,801 USD | — |
| Investing cash flowCash flow statement | — | 5,282,000 USD | — | — | 150,000 USD | — | 150,000 USD | — |
| Operating cash flowCash flow statement | — | -7,975,000 USD | — | — | -6,492,603 USD | — | -5,168,037 USD | — |
| Cash and cash equivalentsBalance sheet | — | — | — | — | 5,881,217 USD | 4,606,289 USD | — | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/05/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.